Loading…
EP2 receptor antagonism reduces peripheral and central hyperalgesia in a preclinical mouse model of endometriosis
Endometriosis is an incurable gynecological disorder characterized by debilitating pain and the establishment of innervated endometriosis lesions outside the uterus. In a preclinical mouse model of endometriosis we demonstrated overexpression of the PGE 2 -signaling pathway (including COX-2, EP 2 ,...
Saved in:
Published in: | Scientific reports 2017-03, Vol.7 (1), p.44169-44169, Article 44169 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Endometriosis is an incurable gynecological disorder characterized by debilitating pain and the establishment of innervated endometriosis lesions outside the uterus. In a preclinical mouse model of endometriosis we demonstrated overexpression of the PGE
2
-signaling pathway (including COX-2, EP
2
, EP
4
) in endometriosis lesions, dorsal root ganglia (DRG), spinal cord, thalamus and forebrain. TRPV1, a PGE
2
-regulated channel in nociceptive neurons was also increased in the DRG. These findings support the concept that an amplification process occurs along the pain neuroaxis in endometriosis. We then tested TRPV1, EP
2
, and EP
4
receptor antagonists: The EP
2
antagonist was the most efficient analgesic, reducing primary hyperalgesia by 80% and secondary hyperalgesia by 40%. In this study we demonstrate reversible peripheral and central hyperalgesia in mice with induced endometriosis. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/srep44169 |